Association of Vitamin D Levels With Kidney Volume in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Open Access
- 24 May 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 6, 112
Abstract
Vitamin D possesses renoprotective effects beyond mineral metabolism, potentially reducing arterial blood pressure and inflammation and vitamin D enzymes (CYP24A1 and CYP27B1) as well as vitamin D receptor (VDR) contribute to its homeostasis. In the present study, we aimed to determine vitamin D association with kidney volume, blood pressure parameters and inflammatory markers in ADPKD. This cross-sectional study, conducted from August 2011 through May 2016, evaluated 25(OH)D, 1,25(OH)2D and other hormonal/biochemical serum and urinary parameters, inflammatory markers and monocyte expression of VDR, CYP24A1, CYP27B1 in 74 ADPKD patients. The height-adjusted total kidney volume (htTKV) was determined by MRI and blood pressure (BP) measured through 24-h ambulatory BP monitoring (ABPM).Vitamin D insufficiency was present in 62% of patients and CYP24A1 was overexpressed in this group, raising a hypothesis of 25(OH)D increased catabolism. Serum 25(OH)D levels and VDR expression were negatively correlated with htTKV as was VDR with IL-6, IL-10, CRP, and NFκB. A multiple linear regression analysis with htTKV as dependent variable, including hypertension, CRP, eGFR, age, time since diagnosis, VDR, and 25(OH)D adjusted for season of the year showed that only the first three parameters were independent predictors of the former. There has been no association of serum 25(OH)D and VDR expression with ABPM parameters. Present findings suggested that low levels of serum 25(OH)D and VDR expression are associated with a higher kidney volume in ADPKD patients, but do not represent independent risk factors for htTKV.Keywords
This publication has 51 references indexed in Scilit:
- Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2012
- Macrophages Promote Cyst Growth in Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2011
- Potentially Modifiable Factors Affecting the Progression of Autosomal Dominant Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- 25-Hydroxyvitamin D Deficiency Is Associated With Inflammation-Linked Vascular Endothelial Dysfunction in Middle-Aged and Older AdultsHypertension, 2011
- Hypertension in Autosomal Dominant Polycystic Kidney DiseaseAdvances in Chronic Kidney Disease, 2010
- Cholecalciferol Supplementation Alters Calcitriol-Responsive Monocyte Proteins and Decreases Inflammatory Cytokines in ESRDJournal of the American Society of Nephrology, 2010
- Evaluation of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease PatientsClinical Journal of the American Society of Nephrology, 2009
- Cardiovascular abnormalities in autosomal-dominant polycystic kidney diseaseNature Reviews Nephrology, 2009
- Unified Criteria for Ultrasonographic Diagnosis of ADPKDJournal of the American Society of Nephrology, 2009
- Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United StatesArchives of internal medicine (1960), 2007